Transfer pricing at heart of Pfizer case
Shareholders allege that Pfizer has deliberately contributed to poor results at its Pakistan operations, thus diluting the value of the minority stakeholders’ shares
Reply to comment
Leela Parker has been quite resourceful in digging up the affairs of Pfizer Laboratories Ltd. Pakistan.Norvasc, Feldene and Vibramycin are marketed by Pfizer as Amologard, Dolonex and Vibazene in India.We now know the price at whichPfizer Pakistan is buying the active ingredients from its parent company.I think Leela Parkershould find out how much Pfizer India is paying for the same raw materials.Readers would certainly be interested as it will throw light on how multinational pharmaceutical companies organise their operations particularly in third world countries.
Javed